- Earth
Science Tech focuses on researching and developing inventive hemp extracts
- The
company has three unique, wholly owned subsidiaries
- ETST
recently reported a significant increase in revenue and gross profit
A science-based biotech company, Earth
Science Tech Inc. (OTCQB: ETST) operates in the hemp-derived cannabinoids,
nutraceuticals, pharmaceuticals, medical-devices, and research and development
(R&D) fields. The company focuses on researching and developing unique hemp
extracts and making those extracts accessible globally. The company offers the
highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol)
oil on the market.
Recently, Earth Science Tech reported a 36 percent revenue
gain as well as a 90 percent increase in gross profit for the quarter ended
June 30, 2019 (http://ibn.fm/ff5C8).
Full-spectrum cannabinoids are propelling the company’s consistent sales. Of
note for investors is that Earth Science Tech earlier reported product sales
totaled $770,635 for fiscal year ending March 31, 2019. This represents a 66.4
percent increase as compared to the $463,108 recorded for the same period in
2018. At the same time, the company maintained an impressive gross profit total
of $295,013 and a gross margin of 38.2 percent in 2019.
The company’s significant revenue success is due in no small
part to its diverse array of subsidiaries. Headquartered in Doral, Florida,
Earth Science Tech has three wholly owned subsidiaries: Earth Science
Pharmaceutical Inc., Cannabis Therapeutics Inc., and Canadian subsidiary Canna
Inno Laboratories Inc.
Earth Science Pharmaceutical concentrates on becoming an
international leader in the development of low-cost, non-invasive diagnostic
tools, medical devices, testing processes, and vaccines for STIs (sexually
transmitted infections and/or diseases). The company is dedicated to developing
pioneering medical devices and vaccines that will improve health worldwide,
particularly for women. ETST’s first medical device is MSN-2, a home kit
designed for the detection of STIs from a self-obtained gynecological specimen.
Earth Science Tech’s Cannabis Therapeutics subsidiary is an
emerging biotech company invested in research and development to explore and
harness the medicinal power of cannabidiol. Cannabis Therapeutics is positioned
to become a world leader in cannabinoid R&D for a wide-ranging line of
cannabinoid-based pharmaceuticals, nutraceuticals and other product solutions.
The company’s initial projects are focused on developing treatments for breast
and ovarian cancers.
The Canna Inno Laboratories subsidiary, a strategic
Montreal-based company, is giving Earth Science Tech a foothold in Quebec.
Canna Inno allows ETST access to Government of Canada funding, the first of
which has recently been approved. This subsidiary will also enable the
advancement of further product via grants offered to pharmaceutical
innovators (http://ibn.fm/6xpLp).
Earth Science Tech’s high-grade, CBD-rich hemp oil is
formulated using a broad array of innovative technologies. The process includes
a super-critical extraction process (CO2), isolation and micron filtration.
Super-critical extraction is a gentle approach and is the key method in the
extraction of the company’s CBD (http://ibn.fm/MC36b).
Earth Science Tech markets a complete line of high-grade,
hemp-CBD oils, hemp-CBD caps, and CBD pet oil products with its full-spectrum
and pure CBD oils. The company’s CBD-rich hemp oil contains no synthetic cannabinoids
and is not an isolate. Rather, the oil contains everything that is naturally
occurring in the original industrial hemp plant. The company’s commercialized
CBD-based product line, High Grade Full Spectrum Cannabinoids, provides seven
distinct cannabinoids, and is formulated to maximize all the therapeutic
benefits the industrial-hemp plant has to offer.
With a management team consisting of industry experts with
decades of experience in the nutraceuticals, dietary-supplements and
life-sciences fields, Earth Science Tech continues to innovate in the CBD
space. The company offers investors a strong platform and exposure to multiple
markets experiencing rapid growth. ETST is consistently executing on its
strategic mission to expand its role as a leader in diverse market sectors.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
